BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$156M |
| 2 |
SPDR Gold Trust
GLD
|
+$142M |
| 3 |
Bank of America
BAC
|
+$107M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$92.9M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.53B |
| 2 |
Equinix
EQIX
|
+$2B |
| 3 |
Gilead Sciences
GILD
|
+$1.63B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.48B |
| 5 |
United Therapeutics
UTHR
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.55% |
| 2 | Technology | 24.39% |
| 3 | Consumer Discretionary | 8.23% |
| 4 | Materials | 5.85% |
| 5 | Real Estate | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HNGR
2301
DELISTED
Hanger Inc.
HNGR
| $17.7K | ﹤0.01% |
449
-9,090
| -95% | -$334K |
|
|
JNY
2302
DELISTED
JONES GROUP INC COM STK (PA)
JNY
| $17.6K | ﹤0.01% |
1,178
-20,957
| -95% | -$304K |
|
2303
Children's Place
PLCE
$53.8M
| $17.5K | ﹤0.01% |
307
-6,021
| -95% | -$326K |
|
2304
Progress Software
PRGS
$1.82B
| $17.4K | ﹤0.01% |
673
-14,621
| -96% | -$378K |
|
|
ARTC
2305
DELISTED
ARTHROCARE CORP
ARTC
| $17.4K | ﹤0.01% |
432
-7,427
| -95% | -$275K |
|
2306
Gold Fields
GFI
$35.7B
| $17.4K | ﹤0.01% |
5,427
-123,459
| -96% | -$505K |
|
|
SCS
2307
DELISTED
Steelcase
SCS
| $17.3K | ﹤0.01% |
1,093
-22,023
| -95% | -$351K |
|
2308
MGE Energy Inc
MGEE
$3.09B
| $17.3K | ﹤0.01% |
449
-8,986
| -95% | -$333K |
|
2309
Halozyme
HALO
$11.2B
| $17.3K | ﹤0.01% |
1,152
-23,080
| -95% | -$297K |
|
2310
Bloomin' Brands
BLMN
$902M
| $17.2K | ﹤0.01% |
716
-14,523
| -95% | -$350K |
|
|
OMG
2311
DELISTED
OM GROUP INC.
OMG
| $17.2K | ﹤0.01% |
472
-8,433
| -95% | -$282K |
|
2312
Forward Air
FWRD
$660M
| $17.2K | ﹤0.01% |
391
-7,655
| -95% | -$319K |
|
2313
J&J Snack Foods
JJSF
$1.68B
| $17.1K | ﹤0.01% |
193
-3,854
| -95% | -$325K |
|
|
FMBI
2314
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $17.1K | ﹤0.01% |
974
-19,563
| -95% | -$331K |
|
|
AYR
2315
DELISTED
Aircastle Ltd
AYR
| $17K | ﹤0.01% |
888
-17,861
| -95% | -$331K |
|
2316
Nektar Therapeutics
NKTR
$2.5B
| $17K | ﹤0.01% |
100
-2,021
| -95% | -$326K |
|
|
MRO
2317
CALL
DELISTED
Marathon Oil Corporation
MRO
| $17K | ﹤0.01% |
+489
| New | +$17.4K |
|
|
ESGR
2318
DELISTED
Enstar Group
ESGR
| $16.9K | ﹤0.01% |
122
-2,497
| -95% | -$342K |
|
2319
Interface
TILE
$2.21B
| $16.9K | ﹤0.01% |
770
-15,563
| -95% | -$314K |
|
|
ITMN
2320
DELISTED
INTERMUNE INC
ITMN
| $16.9K | ﹤0.01% |
1,145
-21,332
| -95% | -$295K |
|
|
GTI
2321
DELISTED
GRAFTECH INTERNATIONAL LTD
GTI
| $16.9K | ﹤0.01% |
1,501
-30,683
| -95% | -$313K |
|
|
CYS
2322
DELISTED
CYS Investments Inc.
CYS
| $16.8K | ﹤0.01% |
2,265
-45,886
| -95% | -$369K |
|
|
ISBC
2323
DELISTED
Investors Bancorp, Inc.
ISBC
| $16.7K | ﹤0.01% |
1,667
-30,552
| -95% | -$283K |
|
2324
PUT
Akamai
AKAM
$17.9B
| $16.7K | ﹤0.01% |
+1,437
| New | +$67.8K |
|
2325
Tootsie Roll Industries
TR
$3.06B
| $16.7K | ﹤0.01% |
+752
| New | +$16.3K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2013 Portfolio in Review
As of Q4 2013, BNP Paribas Financial Markets held 4,298 positions worth $137B, down 0.25% from $137B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
BNP Paribas Financial Markets withdrew a net $60.2B in Q4 2013, closing 193 positions and reducing 1,811 holdings. Its most notable exit was Innoviva, an estimated $182M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, BNP Paribas Financial Markets opened a new position in Ambev worth $22.5M.
- BNP Paribas Financial Markets's largest Q4 2013 buy was Ambev: 3,066,560 shares worth $22.5M.
- BNP Paribas Financial Markets added most to Apple in Q4 2013, an estimated $156M increase.
- BNP Paribas Financial Markets's biggest Q4 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.53B.
- BNP Paribas Financial Markets fully exited Innoviva in Q4 2013, selling an estimated $182M.
- BNP Paribas Financial Markets's ten largest holdings make up 38% of its $137B portfolio in Q4 2013.
- BNP Paribas Financial Markets opened 1,712 new positions and closed 193 in Q4 2013.
- BNP Paribas Financial Markets's portfolio value fell 0.25% quarter-over-quarter to $137B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2013, filed 12 Feb 2014.